SoMex Research & Health Organisation
+91-141-2504996
contact@somexresearch.com
Home
About Us
Board of Directors
Services
News
Login
Careers
Clinical Trials
Current Projects
Ongoing Trials
Past Trials
CME / Academic
Ethics Comittee
Health Survey
Investigators
Media Gallery
Activities Photo Gallery
Video Gallery
Print Media
Contact Us
1
2
3
4
News & Events
Live Webinar - BCOS 2021: 2nd Best Clinical ONCOLOGY SYMPOSIUM, Recent Clinical Updates on LUNGS & BREAST CANCERS, Date: 16 - 17 JUNE 2021, Time: 06 PM - 09 PM
(19/4/2021)
Live Webinar - Impact of Cytogenetics and Molecular Markers in Management of CLL: 16th APRIL 2021, 07:00-08:30 PM IST
(8/4/2021)
Study: 'A Multi Centric Observational Study (BASE) Brivaracetam AssesSment of Epilepsy.'
(31/3/2021)
Experience Sharing Virtual Meeting: Changing the Treatment paradigm in ALK positive NSCLC Patients
(30/3/2021)
Newer Advances in CLL 2021 on 25th Feb 2021
(24/2/2021)
Save the date SoMex is organizing Live streaming on Hepetocellular Carcinoma on 10 Dec 2020
(18/11/2020)
Save the date SoMex Organizing Live streaming on "Recent Advances in Management of NSCLC" on 16th December 2020
(18/11/2020)
SoMex is organizing live streaming on Gastro-Intestinal Cancers on 28th-29th Jan 2021
(18/11/2020)
SoMex organizing Digital Conference on "Pancreatic Cancer Update" on 19 Nov 2020 at 06:30 PM to 08:30 PM
(7/11/2020)
Dr. Naresh Somani, Senior Medical Oncologist will be Live on Facebok for "Lung Cancer Awareness" on 09th Nov 2020 at 07:00 PM to 07:30 PM. Join with us https://www.facebook.com/SomexResearch/live
(4/11/2020)
Target therapy are now available and entrectinib is one of them...
(2/9/2020)
SoMex will organize Virtual meeting "ONCOWEBEX 2020" from 29 Sep 2020 to 30 Sep 2020
(29/8/2020)
SoMex will be organising webinar on "Management of Metastatic Breast Cancer" on 11th September 2020
(28/8/2020)
SoMex can organise webinars and online CME/Conferences for you. We organise everything for you ! From scientific contests to speakers and participants ! For more details contact Manish Kumawat - 0805
(10/7/2020)
Dacomatinib is now available in India for EGFR Positive Lung Cancer. This drug is better than first generation gefitinib and second generation afatinib in many senses.
(22/6/2020)
FDA Approves Pembrolizumab for TMB-High Solid Tumors
(17/6/2020)
Best Clinical Oncolgy symposium 2020 - LIVE Webinars on 10th to 14th June 2020
(25/5/2020)
SoMex organized Virtual Meeting on "Hematology Express- Hemato-Onco Update" on 13th and 14th June 2020
(20/5/2020)
SoMex organized ONCOLOGY UPDATE-Virtual Meeting on 10 to 12 June 2020
(9/5/2020)
Salute to Corono Warriors, Jaipur
(25/4/2020)
CORONA AND CANCER TREATMENT: BY DR NARESH SOMANI ON 10 APRIL 2020
(21/4/2020)
"CANCER CARE DURING COVID-19 PANDEMIC" ON 10 APRIL 2020 AT 02:00 PM BY DR. NARESH SOMANI
(9/4/2020)
Dr. Naresh Somani and Dr. Rajkumari Somani were on leave from 21 to 23 Feb 2020
(14/2/2020)
SoMex organized CME on "Lung Cancer Management and Role of Immunotherapy in first line treatment" on 20th Feb 2020
(11/2/2020)
Meeting of SoMex Research and Health Ethics Committee held on 10 Jan 2020 (Friday) at 05.00 PM
(4/1/2020)
Very soon new and effective treatment for infrequent but deadly skin cancer melanoma is coming with oral pills.
(30/12/2019)
Dr. Naresh Somani was on leave on Saturday 12 Oct 2019
(9/10/2019)
SoMex organized CME on "Lung Cancer Update Post ESMO 2019" on 18th October 2019
(5/9/2019)
SoMex organized CME on Multiple Myeloma on 06 Sep. 2019 (Friday). Dr. Rahul Naithani, Hemato-oncologist, Max Hospital will be guest faculty.
(17/8/2019)
SoMex assesed the data collection in Immunotherapy in Lung Cancer at Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur under Dr. Naresh Somani, MD.DM (Medical Oncology)
(6/8/2019)
Somex organized CME on NSCLC Stage III at Hotel Radisson Blu, Jaipur on 10th May 2019.
(1/5/2019)
Somex organized CME on Immuno Oncology treatment in various Malignancies on 26th April 2019
(27/3/2019)
SoMex organized "3rd Neuro Critical Care Update 2019" on 29th and 30th June 2019 at Pink City Jaipur
(19/3/2019)
SoMex organized "3rd Precision Oncology and Annual International Breast Cancer Conference 2019" from 11th to 13th October 2019 at Pink City Jaipur
(19/3/2019)
2nd Annual IBCC conference organised by SoMex gets RMC accreditation
(20/9/2018)
SoMex organized CME on "Hepato Cellular Cancer" on 14th September 2018 (Friday) for all Oncologists and Gastro Enterologists of Rajasthan
(9/8/2018)
SoMex organized evening CME on "CLL with two International speakers on 5th September 2018 (Wednesday) for all Oncologists of Rajasthan.
(9/8/2018)
SoMex EC meeting is scheduled on 04 Aug 2018
(26/7/2018)
SoMex organized CME on "Lung Cancer" on 20 July 2018
(29/5/2018)
SoMex organized "2nd Annual Indian Breast Cancer Conference" on 5th, 6th and 7th October 2018, at Jaipur.
(1/4/2018)
SoMex organized CME on "Epilepsy awareness talk for general public and felicitation of long term survivors of epilepsy" on 31 March 2018
(31/3/2018)
International Speaker Program on "Breast Cancer : Shifting Paradigms in the treatment of ER+HER2- metastatic Breast Cancer" on Saturday, 17 March 2018.
(7/3/2018)
Immuno Oncology : Spreading its wings in management of various malignancies. A half day CME on 4 th March 18 ( Sunday;10 am to 1 pm . )
(4/3/2018)
Somex organized CME on "Breast Cancer" aims at addressing the challenges & newer approaches for the management of HR+/HER2- Breast Cancer.on 23rd February 2018 (Friday)
(23/2/2018)
CME on newer aspects in management of metastatic Breast cancer and advisory board meeting of Key Opinion Leaders on 23 rd December, 18.
(20/2/2018)
Somex organized CME on ROS-1 Positive Lung Cancer on 31st Jan 2018
(13/1/2018)
Ribociclib has been granted breakthrough therapy designation for use in combination with tamoxifen or an AI)= as frontline treatment for pre- or perimenopausal women with HR+ HER2– advanced or metasta
(8/1/2018)
SoMex Organised CME on Advance Breast Cancer: KEEPING CHEMOTHERAPHY AWAY!!! on 3rd November 2017
(28/10/2017)
Janssen representative received the Silver Encore Award for successfully coordinating and executing the CME on "Multiple Myeloma way forward" on 28th July 2017 with Somex.
(1/9/2017)
We are pleased to invite you that SoMex is Organizing IBCC (Indian Breast Cancer Conference) at Jaipur On 7 & 8 Oct 2017
(25/8/2017)
SoMex organized CME on Multiple Myeloma on 28th July 2017 at Hotal Radission Blu, Jaipur
(20/7/2017)
SoMex supported an International Speaker Symposium on "RENAL CELL CARCINOMA 2017" on 2nd August, 2017
(14/7/2017)
19th Annual National Conference on Emergency Medicine EMCON2017 to be held in Jaipur, Rajasthan on behalf of Society for Emergency Medicine India (SEMI)
(21/6/2017)
SoMex Organised CME on Lung Cancer (NSCLC) for Oncologist of Rajasthan on 30th June 2017 at 8:00 PM at Hotel Raddison at
(13/6/2017)
SoMex organised CME on " 2ND NEURO CRITICAL CARE UPDATE 2017" at Jaipur on 22nd & 23 July 2017
(1/6/2017)
SoMex organized CME on "Managing NSCLC beyond first line in driver mutation negative Patients & what's new in this ASCO" at Jaipur on 09th June 2017.
(1/6/2017)
Cancer Immunotherapy is now a reality!!!
(8/5/2017)
International Clinical Trail Day - 20th May 2017
(5/5/2017)
CME organized on " Integrating Comprehensive Genomic Profiling into your clinical practice" on 19th May 2017
(29/4/2017)
CME on Lung Cancer on 7th of April 2017 in Jaipur at Hotel Hilton, Hawa Sadak Jaipur. Speaker Dr Simon George
(5/4/2017)
New Clinical trial started:MYL-1402O-3001 : at Multicentre in the first line treatment of Patient with Stage IV Non-Squamous Non-Small Cell Lung Cancer
(10/3/2017)
Dr. Naresh Somani has been appointed as lead investigator of India for a multinational phase 2/3 clinical trial of Lung Cancer by Unitech, USA.
(8/2/2017)
Ethics Committee Meeting held on 10 September 2016 at 5:00 PM
(12/9/2016)
SoMex organized Neuro update CME at Hotel Green, Jaipur on 13th and 14th August 2016
(3/8/2016)
Clause of Mamimum 3 Trials for one Principal Investigator is removed. One PI now can do more trials based on Ethics Committee Recommendation.
(2/8/2016)
International Speaker Program on Metastatic Breast Cancer on12 July 2016
(24/5/2016)
Second Voice App-As one for Head and Neck Cancer Patients
(7/5/2016)
Join us on Twitter@DrNSomani
(31/3/2016)
somex research web site is tracked by more than 11,000 viewers
(31/3/2016)
Astella Pharma is lunching Enzalutamide ( XTANDI ) for Metastatic Castration Resistant Prostate Cancer in India
(28/3/2016)
Next CME on 'Metastatic NSCLC (EGFR and ALK INHIBITOR)' on 23 April 2016
(28/3/2016)
Next Ethic Committee Meeting Scheduled on 9 April 2016, Saturday, 4.30 PM to 5.30 PM
(28/3/2016)
CME on "Metastatic Colo-Rectal Cancer" on 5 March 2016
(17/2/2016)
Dr. Mumtaz Ali, Critical Care Specialist & Member of SoMex Academic Committee, awarded for Young Achiever award by Health Minister of Rajasthan on Doctor's Day (01/07/2016)
(7/1/2016)
Next Ethics Meeting Scheduled on 31 Oct 2015 at 4:30 PM
(29/10/2015)
Neuro Critical Care Updates-2015
(18/8/2015)
Next ethics committee meeting scheduled on 22 Aug 2015.
(11/8/2015)
Uro-Onco Scientific Meeting 2015
(8/8/2015)
Workshop on Good Clinical Practice (GCP)
(24/7/2015)
CME on 'EARLY BREAST CANCER'
(29/1/2015)
SoMex launched Health Survey on Jaipur Doctors
(29/1/2015)
CME on 'Management of Metastatic Colorectal Cancer (mCRC'
(11/12/2014)
Follicular lymphoma
(18/8/2014)
Head & Neck Squamous Cell Carcinoma.
(18/8/2014)
Non-small cell lung cancer
(18/8/2014)
Awareness talk on Bones & Joints presented by Dr. Anup Jhurani on 6 Sept. 2013
(2/9/2013)
Investigator initiated study
(14/8/2013)
Health Awareness talk on 26 July 13 by Dr. Anup Jhurani
(13/7/2013)
Presentation on treatment of Head & Neck cancer with Target-Therapy (NIMOTUZUMAB)
(2/5/2013)
Next ethics committee meeting scheduled on 13th April 2013.
(4/4/2013)
Somex research & health ethics committee registered with DCGI
(13/3/2013)
CME on Myelo Dysplatic Syndrome
(26/12/2012)
Crizotinib for lung cancer in India
(26/12/2012)
Emerging evidence of Nimotuzumab (BioMab EGFR) in Esophageal Cancers
(2/11/2012)
Phase I Trial Managed by SoMex Research & Health Published in ASCO 2012
(25/5/2012)
Clinical Trial opportunity for patients
(3/2/2012)
Presentation on 16 Dec 2011.
(9/12/2011)
(19/4/2021)
+91-141-2504996 
1
2
3
4